Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Avapritinib
.
Show all posts
Showing posts with label
Avapritinib
.
Show all posts
Thursday, January 30, 2020
Blueprint Medicines Announces FDA Acceptance of New Drug Application for Avapritinib for the Treatment of PDGFRA Exon 18 Mutant GIST and Fourth-Line GIST
›
Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases ...
›
Home
View web version
